EP3873904
TVÍSÝKLÍSK PÝRIMÍDÍNDÍÓN EFNASAMBÖND SETIN AF TETRAHÝDRÓPÝRAN (THP)
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
28.10.2019EP published:
10.7.2024EP application number:
19817827.9
EP translation filed:
29.8.2024Grant published:
15.10.2024EPO information:
European Patent Register
Max expiry date:
27.10.2039Expiry date:
27.10.2026Next due date:
31.10.2026
Title in English:
TETRAHYDROPYRAN (THP)-SUBSTITUTED BICYCLIC-PYRIMIDINEDIONE COMPOUNDSLanguage of the patent:
English
Timeline
Today
28.10.2019EP application
10.7.2024EP Publication
29.8.2024Translation submitted
15.10.2024Registration published
27.10.2026Expires
Owner
Name:
MyoKardia, Inc.Address:
1000 Sierra Point Parkway, Brisbane CA 94005, US
Inventor
Name:
GRILLO, MarkAddress:
Brisbane, CA 94005, US
Name:
KANE, BrianAddress:
Brisbane, CA 94005, US
Name:
OSLOB, JohanAddress:
Brisbane, CA 94005, US
Name:
ZHONG, MinAddress:
Brisbane, CA 94005, US
Name:
THOMPSON, FabienneAddress:
75008 Paris, FR
Agent
Name:
Zacco Denmark A/SAddress:
Arne Jacobsens Allé 15, DK
Priority
Number:
201862752278 PDate:
29.10.2018Country:
US
Classification
Categories:
C07D 471/04, A61P 9/00, A61K 31/4745
Annual fees
Number
Paid
Expires
Payer
Number: 6
Paid: 17.9.2024
Expires: 27.10.2025
Payer: Árnason Faktor ehf.
Number: 7
Paid: 10.10.2025
Expires: 27.10.2026
Payer: Árnason Faktor ehf.